TapewireFind a company

person · Reporting owner

McDade Ralph L

Disclosed activity across 1 company

Tapewire entity
154672
SEC CIK
0001594674

Export transaction history ↓

Reported relationships

Latest disclosed role at each company.

CompanyLast reported asReport datePublished
MYRIAD GENETICS INCMYGN · Entity 5953President Myriad RBM, Inc.September 30, 2019October 01, 2019

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

MYRIAD GENETICS INC

Report date September 30, 2019 · Filed October 01, 2019

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeDirect142,095 Ending reported balance After 2019-09-30 transaction · row 2
2 source rows · reconciled sequence

Row 1 · 2019-09-30 · Disposition to issuer · Disposed 2,361 · Balance 145,047

F1: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person.

Row 2 · 2019-09-30 · Disposition to issuer · Disposed 2,952 · Balance 142,095

F1: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person.

Filing footnotes · ownership attribution and instrument terms

F1: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person.

Transaction history

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateCompanyActivity / securityShares / unitsReported priceReported valueDetails
September 30, 2019 Filed Oct 1, 2019 22:39 UTC MYRIAD GENETICS INC MYGN · Entity 5953 Disposition to issuerCommon Stock 2,952 $28.63 $84,515.76
Disclosure

SEC source: 0001594674-19-000006 · edgardoc.xml · nonDerivative · entry 2

McDade Ralph L · CIK 0001594674 · President Myriad RBM, Inc.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 142,095

F1 · kind: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person.

Read SEC document
September 30, 2019 Filed Oct 1, 2019 22:39 UTC MYRIAD GENETICS INC MYGN · Entity 5953 Disposition to issuerCommon Stock 2,361 $28.63 $67,595.43
Disclosure

SEC source: 0001594674-19-000006 · edgardoc.xml · nonDerivative · entry 1

McDade Ralph L · CIK 0001594674 · President Myriad RBM, Inc.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 145,047

F1 · kind: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person.

Read SEC document
September 25, 2019 Filed Sep 26, 2019 21:11 UTC MYRIAD GENETICS INC MYGN · Entity 5953 GrantCommon Stock 30,000 $0.00 $0.00
Disclosure

SEC source: 0001594674-19-000004 · edgardoc.xml · nonDerivative · entry 3

McDade Ralph L · CIK 0001594674 · President Myriad RBM, Inc.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 147,408

F2 · kind: Consists of restricted stock units granted pursuant to the Company's 2017 Employee, Director and Consultant Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of the Company's common stock and vests 25% on September 26, 2020, 25% on September 26, 2021, 25% on September 26, 2022, and 25% on September 26, 2023.

Read SEC document
September 25, 2019 Filed Sep 26, 2019 21:11 UTC MYRIAD GENETICS INC MYGN · Entity 5953 Disposition to issuerCommon Stock 2,952 $29.93 $88,353.36
Disclosure

SEC source: 0001594674-19-000004 · edgardoc.xml · nonDerivative · entry 2

McDade Ralph L · CIK 0001594674 · President Myriad RBM, Inc.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 117,408

F1 · kind: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person.

Read SEC document
September 25, 2019 Filed Sep 26, 2019 21:11 UTC MYRIAD GENETICS INC MYGN · Entity 5953 Disposition to issuerCommon Stock 2,657 $29.93 $79,524.01
Disclosure

SEC source: 0001594674-19-000004 · edgardoc.xml · nonDerivative · entry 1

McDade Ralph L · CIK 0001594674 · President Myriad RBM, Inc.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 120,360

F1 · kind: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person.

Read SEC document
March 12, 2019 Filed Mar 12, 2019 21:56 UTC MYRIAD GENETICS INC MYGN · Entity 5953 SaleCommon Stock 1,975 $31.00 $61,225.00
Disclosure

SEC source: 0001594674-19-000002 · edgardoc.xml · nonDerivative · entry 1

McDade Ralph L · CIK 0001594674 · President Myriad RBM, Inc.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 122,604

Read SEC document
September 30, 2018 Filed Oct 2, 2018 13:18 UTC MYRIAD GENETICS INC MYGN · Entity 5953 Disposition to issuerCommon Stock 2,952 $46.00 $135,792.00
Disclosure

SEC source: 0001594674-18-000008 · edgardoc.xml · nonDerivative · entry 2

McDade Ralph L · CIK 0001594674 · President Myriad RBM, Inc.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 124,265

F1 · kind: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person.

Read SEC document
September 30, 2018 Filed Oct 2, 2018 13:18 UTC MYRIAD GENETICS INC MYGN · Entity 5953 Disposition to issuerCommon Stock 2,361 $46.00 $108,606.00
Disclosure

SEC source: 0001594674-18-000008 · edgardoc.xml · nonDerivative · entry 1

McDade Ralph L · CIK 0001594674 · President Myriad RBM, Inc.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 127,217

F1 · kind: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person.

Read SEC document
September 25, 2018 Filed Sep 26, 2018 18:20 UTC MYRIAD GENETICS INC MYGN · Entity 5953 Disposition to issuerCommon Stock 2,952 $46.65 $137,710.80
Disclosure

SEC source: 0001594674-18-000006 · edgardoc.xml · nonDerivative · entry 1

McDade Ralph L · CIK 0001594674 · President Myriad RBM, Inc.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 129,578

F1 · kind: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person.

Read SEC document
September 19, 2018 Filed Sep 21, 2018 16:27 UTC MYRIAD GENETICS INC MYGN · Entity 5953 GrantCommon Stock 27,000 $0.00 $0.00
Disclosure

SEC source: 0001594674-18-000004 · edgardoc.xml · nonDerivative · entry 1

McDade Ralph L · CIK 0001594674 · President Myriad RBM, Inc.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 132,530

F1 · kind: Consists of restricted stock units granted pursuant to the Company's 2017 Employee, Director and Consultant Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of the Company's common stock and vests 25% on September 25, 2019, 25% on September 25, 2020, 25% on September 25, 2021, and 25% on September 25, 2022.

Read SEC document
September 17, 2018 Filed Sep 18, 2018 18:18 UTC MYRIAD GENETICS INC MYGN · Entity 5953 Disposition to issuerCommon Stock 3,148 $46.35 $145,909.80
Disclosure

SEC source: 0001594674-18-000002 · edgardoc.xml · nonDerivative · entry 1

McDade Ralph L · CIK 0001594674 · President Myriad RBM, Inc.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 105,530

F1 · kind: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person.

Read SEC document
September 30, 2017 Filed Oct 3, 2017 20:48 UTC MYRIAD GENETICS INC MYGN · Entity 5953 Disposition to issuerCommon Stock 2,052 $36.18 $74,241.36
Disclosure

SEC source: 0001594674-17-000006 · edgardoc.xml · nonDerivative · entry 2

McDade Ralph L · CIK 0001594674 · President Myriad RBM, Inc.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 108,184

F1 · kind: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person.

Read SEC document
September 30, 2017 Filed Oct 3, 2017 20:48 UTC MYRIAD GENETICS INC MYGN · Entity 5953 Disposition to issuerCommon Stock 1,641 $36.18 $59,371.38
Disclosure

SEC source: 0001594674-17-000006 · edgardoc.xml · nonDerivative · entry 1

McDade Ralph L · CIK 0001594674 · President Myriad RBM, Inc.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 110,236

F1 · kind: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person.

Read SEC document
September 17, 2017 Filed Sep 19, 2017 21:45 UTC MYRIAD GENETICS INC MYGN · Entity 5953 Disposition to issuerCommon Stock 2,188 $33.05 $72,313.40
Disclosure

SEC source: 0001594674-17-000004 · edgardoc.xml · nonDerivative · entry 1

McDade Ralph L · CIK 0001594674 · President Myriad RBM, Inc.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 111,877

F1 · kind: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person.

Read SEC document
September 13, 2017 Filed Sep 15, 2017 20:41 UTC MYRIAD GENETICS INC MYGN · Entity 5953 GrantCommon Stock 30,000 $0.00 $0.00
Disclosure

SEC source: 0001594674-17-000002 · edgardoc.xml · nonDerivative · entry 1

McDade Ralph L · CIK 0001594674 · President Myriad RBM, Inc.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 114,065

F1 · kind: Consists of restricted stock units granted pursuant to the Company's 2010 Employee, Director and Consultant Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of the Company's common stock and vests 25% on September 25, 2018, 25% on September 25, 2019, 25% on September 25, 2020, and 25% on September 25, 2021.

Read SEC document
September 30, 2016 Filed Oct 3, 2016 21:53 UTC MYRIAD GENETICS INC MYGN · Entity 5953 Disposition to issuerCommon Stock 1,641 $20.58 $33,771.78
Disclosure

SEC source: 0001594674-16-000019 · edgardoc.xml · nonDerivative · entry 1

McDade Ralph L · CIK 0001594674 · President Myriad RBM, Inc.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 82,891

F1 · kind: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person.

Read SEC document
September 17, 2016 Filed Sep 20, 2016 13:08 UTC MYRIAD GENETICS INC MYGN · Entity 5953 Disposition to issuerCommon Stock 2,188 $20.92 $45,772.96
Disclosure

SEC source: 0001594674-16-000017 · edgardoc.xml · nonDerivative · entry 1

McDade Ralph L · CIK 0001594674 · President Myriad RBM, Inc.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 84,532

F1 · kind: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person.

Read SEC document
September 14, 2016 Filed Sep 16, 2016 18:24 UTC MYRIAD GENETICS INC MYGN · Entity 5953 GrantCommon Stock 30,000 $0.00 $0.00
Disclosure

SEC source: 0001594674-16-000015 · edgardoc.xml · nonDerivative · entry 1

McDade Ralph L · CIK 0001594674 · President Myriad RBM, Inc.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 86,720

F1 · kind: Consists of restricted stock units granted pursuant to the Company's 2010 Employee, Director and Consultant Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of the Company's common stock and vests 25% on September 30, 2017, 25% on September 30, 2018, 25% on September 30, 2019, and 25% on September 30, 2020.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.